Research programme: Non narcotic analgesics - Vapogenix
Latest Information Update: 16 Feb 2017
At a glance
- Originator University of Texas M. D. Anderson Cancer Center; Vapogenix
- Class Anaesthetics; Analgesics; Anti-inflammatories; Non-opioid analgesics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Pain
- Research Inflammatory pain
Most Recent Events
- 16 Feb 2017 Early research in Inflammatory pain in USA (Topical) (Texas Emerging Technology pipeline, January 2017)